Global Cord Blood Competitors

Social Capital Hedosophia Holdings Corp. V (NYSE:IPOE) and Global Cord Blood (NYSE:CO) are both small-cap unclassified companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, valuation, risk and analyst recommendations.

Profitability

This table compares Social Capital Hedosophia Holdings Corp. V and Global Cord Blood's net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Social Capital Hedosophia Holdings Corp. V and Global Cord Blood, as provided by MarketBeat.

Valuation & Earnings

This table compares Social Capital Hedosophia Holdings Corp. V and Global Cord Blood's top-line revenue, earnings per share (EPS) and valuation.

Global Cord Blood has higher revenue and earnings than Social Capital Hedosophia Holdings Corp. V.

Summary

Global Cord Blood beats Social Capital Hedosophia Holdings Corp. V on 4 of the 4 factors compared between the two stocks.

Global Cord Blood (NYSE:CO) and Social Capital Hedosophia Holdings Corp. VI (NYSE:IPOF) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends.

Profitability

This table compares Global Cord Blood and Social Capital Hedosophia Holdings Corp. VI's net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Global Cord Blood and Social Capital Hedosophia Holdings Corp. VI, as reported by MarketBeat.

Valuation & Earnings

This table compares Global Cord Blood and Social Capital Hedosophia Holdings Corp. VI's gross revenue, earnings per share (EPS) and valuation.

Global Cord Blood has higher revenue and earnings than Social Capital Hedosophia Holdings Corp. VI.

Summary

Global Cord Blood beats Social Capital Hedosophia Holdings Corp. VI on 4 of the 4 factors compared between the two stocks.

Global Cord Blood (NYSE:CO) and Paya (NASDAQ:PAYA) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends.

Risk and Volatility

Global Cord Blood has a beta of 0.39, meaning that its stock price is 61% less volatile than the S&P 500. Comparatively, Paya has a beta of 0.05, meaning that its stock price is 95% less volatile than the S&P 500.

Profitability

This table compares Global Cord Blood and Paya's net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Global Cord Blood and Paya, as reported by MarketBeat.

Paya has a consensus price target of $15.75, suggesting a potential upside of 39.38%. Given Paya's higher possible upside, analysts clearly believe Paya is more favorable than Global Cord Blood.

Valuation & Earnings

This table compares Global Cord Blood and Paya's gross revenue, earnings per share (EPS) and valuation.

Global Cord Blood has higher revenue and earnings than Paya.

Institutional and Insider Ownership

41.2% of Paya shares are held by institutional investors. 1.5% of Paya shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Global Cord Blood beats Paya on 6 of the 11 factors compared between the two stocks.

Global Cord Blood (NYSE:CO) and Foley Trasimene Acquisition (NYSE:WPF) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends.

Profitability

This table compares Global Cord Blood and Foley Trasimene Acquisition's net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Global Cord Blood and Foley Trasimene Acquisition, as reported by MarketBeat.

Valuation & Earnings

This table compares Global Cord Blood and Foley Trasimene Acquisition's gross revenue, earnings per share (EPS) and valuation.

Global Cord Blood has higher revenue and earnings than Foley Trasimene Acquisition.

Institutional and Insider Ownership

0.1% of Foley Trasimene Acquisition shares are held by institutional investors. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Global Cord Blood beats Foley Trasimene Acquisition on 4 of the 5 factors compared between the two stocks.

Global Cord Blood (NYSE:CO) and Porch Group (NASDAQ:PRCH) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends.

Profitability

This table compares Global Cord Blood and Porch Group's net margins, return on equity and return on assets.

Institutional and Insider Ownership

97.8% of Porch Group shares are held by institutional investors. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Global Cord Blood and Porch Group, as reported by MarketBeat.

Porch Group has a consensus price target of $25.3333, suggesting a potential upside of 61.98%. Given Porch Group's higher possible upside, analysts clearly believe Porch Group is more favorable than Global Cord Blood.

Valuation & Earnings

This table compares Global Cord Blood and Porch Group's gross revenue, earnings per share (EPS) and valuation.

Global Cord Blood has higher revenue and earnings than Porch Group.

Summary

Global Cord Blood beats Porch Group on 4 of the 7 factors compared between the two stocks.

Global Cord Blood (NYSE:CO) and Star Peak Energy Transition (NYSE:STPK) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, profitability, institutional ownership and earnings.

Profitability

This table compares Global Cord Blood and Star Peak Energy Transition's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of current ratings for Global Cord Blood and Star Peak Energy Transition, as reported by MarketBeat.com.

Earnings and Valuation

This table compares Global Cord Blood and Star Peak Energy Transition's gross revenue, earnings per share (EPS) and valuation.

Global Cord Blood has higher revenue and earnings than Star Peak Energy Transition.

Summary

Global Cord Blood beats Star Peak Energy Transition on 4 of the 4 factors compared between the two stocks.